Icon2

Medical Publisher Looks into Lawmaker’s Allegation of Misrepresentation

The NYT is reporting that, because mainly of allegations made by Sen. Charles Grassley (R-IA), a medical publishing company plans to investigate an article “improperly” ghostwritten by pharma giant Wyeth to promote its patented estrogen, Prempro. Medical ghostwriting is not a new practice. It’s merely just another promotional tool in marketing a pharma company’s product, end user beware. The problem arises, however, when the ugly spectre of misrepresentation occurs. Intentional or apparent? | LINK

Related Posts Within Doctor Pundit:

  1. CA Lawmaker Supports Ban on Certain DTAs A top Democrat lawmaker supports reining in direct-to-consumer advertising (DTA)...
  2. Medical Student Org Publicizes Medical Schools’ Pharma Policies In a way, the “predation” of pharma companies on medical...
  3. Iowa Senator Continues Investigation into Medical Ghostwriting To Senator Charles Grassley (R-IA) ghostwriting and plagiarism fall within...

Leave a Reply

Doctor Pundit Featured Video

Scott Brown U.S. Sen. Victory Speech (1/19/10)

Courtesy Fox News

Follow Doctor Pundit Updates (Tweets) Via Twitter

Posting tweet...

HHS Healthy People 2020 Interactive Campaign

Care About a Healthier Nation? We Want Your Input - Developing Healthy People 2020

DP Site Stats At A Glance

SEO Powered by Platinum SEO from Techblissonline